Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00544713 · ClinicalTrials.gov registry record · NA
Evaluate the Safety and Efficacy of a New Artificial Tear for Use After LASIK Surgery
A NA study, sponsored by Allergan.
- Completed
- Registry status
- NA
- Development phase
- 228
- Enrollment target
NCT00544713: Completed NA study, sponsored by Allergan.
NCT00544713 is a NA study that has completed, run by Allergan. The registered enrollment target is 228 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (84% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00544713, a NA study, has completed, sponsored by Allergan.
- COMPLETED
- Registry status
- NA
- Development phase
- 228 participants
- Enrollment target
Study Summary
This study will evaluate the safety and efficacy of a new artificial tear for the treatment of dry eye that may occur after LASIK surgery
Primary Outcome
Measured on 12 domains (categories); a 5-point scale for each domain (0 = best, no dry eye symptoms, 4 = worst, constant dry eye symptoms). Sum of the domain scores is normalized (standardized) to a severity scale of 0-100 (0 = no symptoms (best score), 100 = maximum severity (worst score)).
Interventions
- DRUG Carboxymethylcellulose and Glycerin based artificial tear
- DRUG Carboxymethylcellulose
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 228 participants |
| Start Date | 2007-09 |
| Est. Completion | 2008-06 |
| Phase | NA |
What the finished NCT00544713 record still lists
NCT00544713 is an interventional study that assigns participants to a tested intervention. The registered 228 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (84% lower).
The record links to 0 conditions, and to 2 interventions - of which Carboxymethylcellulose and Glycerin based artificial tear is the first listed.
NCT00544713 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00544713 about?
NCT00544713 is a clinical study titled "Evaluate the Safety and Efficacy of a New Artificial Tear for Use After LASIK Surgery". This study will evaluate the safety and efficacy of a new artificial tear for the treatment of dry eye that may occur after LASIK surgery
What is the current status of trial NCT00544713?
This trial is currently completed. It is a NA study. The enrollment target is 228 participants. The study started on 2007-09. Estimated completion is 2008-06.
What interventions are being tested in trial NCT00544713?
The interventions under investigation include: Carboxymethylcellulose and Glycerin based artificial tear (DRUG), Carboxymethylcellulose (DRUG).
Who is sponsoring clinical trial NCT00544713?
This trial is sponsored by Allergan, which has 314 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00544713's enrollment target sits among peer trials
228 468th of 2000 higher than 1,530 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05107908 · 228 participants · NA
Neuronal and Behavioral Effects of an Implicit Priming Approach to Improve Eating Behaviors in Obesity
- NCT05547698 · 228 participants · NA
A Study of Venoarterial ECMO vs Off-Pump Bilateral Orthotopic Lung Transplantation
- NCT05630963 · 228 participants
Beyond Monoamines: The Role of the Nociceptin/Orphanin FQ Receptor in Major Depression
- NCT06073665 · 228 participants · Phase 4
Dosing of LT4 in Older Individuals
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia